Drug combinations and the bioavailability of rifampicin.
Fox
W
W
University of London, UK.
D000995:Antitubercular Agents / Q000627:therapeutic use*; D001682:Biological Availability; D004338:Drug Combinations; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000493:pharmacokinetics* / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy / Q000378:metabolism
D000995:Antitubercular Agents; D004338:Drug Combinations; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin